Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
The central figure from the study "Predictors and Variation in Cardiac Rehabilitation Participation After Transcatheter Aortic Valve Replacement study 2023," showing the wide variation in the percentage of patients who receive post-TAVR rehab among TAVR patients in Michigan.

Less than one-third of TAVR patients enter cardiac rehab

Only about 30% of patients who underwent TAVR in Michigan participated in cardiac rehabilitation within 90 days after discharge.

Direct acyclic graph representing a causal structural model of mediation of the association between obesity in early pregnancy and cardiovascular disease (CVD) risk factors after delivery. E indicates exposure; GDM, gestational diabetes; HDP, hypertensive disorders of pregnancy; M, mediators; O, outcome; PTB, preterm birth; SBP, systolic blood pressure; SGA, small-for-gestational-age birth; and TC, total cholesterol. *Variable included in sensitivity analysis.

Pregnancy complications increase and unmask cardiovascular risks in obese patients in NIH study

New research is providing a broader understanding of how cardiovascular disease risk manifests following pregnancy. Having obesity before and during early pregnancy appears to be a strong indicator of risk for developing future cardiovascular disease and was significantly linked with adverse outcomes during pregnancy.

Specialists at Cleveland Clinic treated a hypertrophic cardiomyopathy patient with a new gene therapy from Tenaya Therapeutics

Cleveland Clinic treats first patient with new gene therapy for hypertrophic cardiomyopathy

Researchers hopes this first-in-class gene therapy, known as TN-201, can restore the patient’s MYBPC3 levels and eventually lead to disease reversal.

No, a popular blood pressure medication does not increase heart failure risk, new research confirms

Dihydropyridines such as amlodipine have been the topic of some debate in recent months due to fears they lead to significant side effects. 

Medtronic's Evolut FX TAVR valve, designed with 3 golden markers that improve alignment

Medtronic receives CE mark approval for Evolut FX TAVR system

The self-expanding valve, already approved by the FDA, was designed with three gold markers to boost implanter efficiency, an updated catheter tip and a more flexible delivery system.

Newsweek ranked the 50 best heart hospitals in the world

One-stop cardiology clinic opens, offering same-day CVD diagnoses

The new healthcare facility is the first of its kind, offering same-day cardiac imaging scans, cardiologist consultations and diagnoses. 

Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

FDA warns Abiomed about ‘significant violations’ related to its Impella heart pumps

The agency said Abiomed did not seek the necessary approvals for one Impella-related device and was slow to act on certain safety concerns. 

Does X still mark the spot for cardiologists? The risks and benefits of using Twitter in 2023 and beyond

Should interventional cardiologists be using X, the website formerly known as Twitter? A team of specialists explored that very question, sharing its assessment in JSCAI.

Displaying 809 - 816 of 10748

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.